Unexpectedly, neither obesity as defined by a body mass index (BMI) above 30 kg/m2 (Figure 1(c)) nor preexisting type 2 diabetes (Figure 1(d)) was associated with visfatin serum concentrations. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.